A detailed history of Scott & Selber, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Scott & Selber, Inc. holds 45,035 shares of MRK stock, worth $4.94 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares
45,035
Previous 44,328 1.59%
Holding current value
$4.94 Million
Previous $5.85 Million 4.68%
% of portfolio
1.78%
Previous 1.99%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$123.8 - $132.96 $87,526 - $94,002
707 Added 1.59%
45,035 $5.58 Million
Q1 2024

May 01, 2024

BUY
$113.24 - $131.95 $8,832 - $10,292
78 Added 0.18%
44,328 $5.85 Million
Q4 2023

Feb 01, 2024

SELL
$100.18 - $109.02 $46,383 - $50,476
-463 Reduced 1.04%
44,250 $4.82 Million
Q3 2023

Oct 24, 2023

SELL
$102.95 - $114.33 $15,442 - $17,149
-150 Reduced 0.33%
44,713 $4.6 Million
Q2 2023

Jul 27, 2023

SELL
$108.61 - $118.38 $19,115 - $20,834
-176 Reduced 0.39%
44,863 $5.18 Million
Q1 2023

Apr 18, 2023

BUY
$102.94 - $114.86 $11,323 - $12,634
110 Added 0.24%
45,039 $4.79 Million
Q4 2022

Jan 31, 2023

BUY
$87.44 - $112.11 $6,820 - $8,744
78 Added 0.17%
44,929 $4.99 Million
Q3 2022

Oct 21, 2022

BUY
$84.53 - $94.96 $18,934 - $21,271
224 Added 0.5%
44,851 $3.86 Million
Q2 2022

Jul 28, 2022

BUY
$83.49 - $94.64 $30,473 - $34,543
365 Added 0.82%
44,627 $4.07 Million
Q1 2022

May 03, 2022

SELL
$73.51 - $82.4 $243,979 - $273,485
-3,319 Reduced 6.98%
44,262 $3.63 Million
Q4 2021

Feb 04, 2022

BUY
$72.28 - $90.54 $221,755 - $277,776
3,068 Added 6.89%
47,581 $3.65 Million
Q3 2021

Nov 05, 2021

BUY
$71.68 - $78.83 $1.46 Million - $1.61 Million
20,423 Added 84.78%
44,513 $3.34 Million
Q2 2021

Aug 10, 2021

BUY
$70.31 - $77.77 $1.69 Million - $1.87 Million
24,090 New
24,090 $1.87 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $278B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Scott & Selber, Inc. Portfolio

Follow Scott & Selber, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott & Selber, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scott & Selber, Inc. with notifications on news.